Invention Grant
US07790717B2 Spiro-oxazolidinone compounds and their use as metabotropic glutamate receptor potentiators
失效
螺恶唑烷酮化合物及其作为代谢型谷氨酸受体增强剂的用途
- Patent Title: Spiro-oxazolidinone compounds and their use as metabotropic glutamate receptor potentiators
- Patent Title (中): 螺恶唑烷酮化合物及其作为代谢型谷氨酸受体增强剂的用途
-
Application No.: US12353056Application Date: 2009-01-13
-
Publication No.: US07790717B2Publication Date: 2010-09-07
- Inventor: Ian Egle , Babu Joseph , Abdelmalik Slassi , Methvin Isaac , Fupeng Ma , Joshua Clayton
- Applicant: Ian Egle , Babu Joseph , Abdelmalik Slassi , Methvin Isaac , Fupeng Ma , Joshua Clayton
- Applicant Address: SE Sodertalje
- Assignee: AstraZeneca AB
- Current Assignee: AstraZeneca AB
- Current Assignee Address: SE Sodertalje
- Agent Kenneth F. Mitchell
- Main IPC: A61K31/5377
- IPC: A61K31/5377 ; A61K31/423
Abstract:
Compounds in accord with Formula I: wherein R1, L, A, B, D, E, m, n, x and y are as defined in the description, processes for the preparation of such compounds and to new intermediates employed in the preparation thereof, pharmaceutical compositions containing such compounds, and the use of such compounds in therapy and for the treatment of diseases mentioned in the specification.
Public/Granted literature
- US20090124578A1 SPIRO-OXAZOLIDINONE COMPOUNDS AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR POTENTIATORS Public/Granted day:2009-05-14
Information query
IPC分类:
